Neuromod Newsroom

Neuromod Closes €10m Financing to Accelerate Lenire Availability

Lenire Controlled Clinical Trial Published in Nature Communications

Lenire Now a Treatment Option Through Veterans Affairs

Neuromod Appoints Tom Maher as General Counsel

Neuromod Announces Finance Leadership Reorganisation

Neuromod Closes €30 Million Financing

FDA Grants Lenire De Novo Approval

Lenire Now Available in Hungary

Lenire Tinnitus Treatment Device Now Available in Denmark

Stay in the Loop

Register for the Neuromod Newsletter to stay up to date on hearing and tinnitus industry news, emerging tinnitus research, and all things Neuromod and Lenire.